These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 10694440

  • 21. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
    Lakka SS, Rajagopal R, Rajan MK, Mohan PM, Adachi Y, Dinh DH, Olivero WC, Gujrati M, Ali-Osman F, Roth JA, Yung WK, Kyritsis AP, Rao JS.
    Clin Cancer Res; 2001 Apr; 7(4):1087-93. PubMed ID: 11309361
    [Abstract] [Full Text] [Related]

  • 22. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
    Yue J, Sun B, Liu G, Mulder KM.
    J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
    [Abstract] [Full Text] [Related]

  • 23. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
    Henic E, Sixt M, Hansson S, Høyer-Hansen G, Casslén B.
    Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158
    [Abstract] [Full Text] [Related]

  • 24. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Cancer Res; 2003 May 15; 63(10):2454-61. PubMed ID: 12750266
    [Abstract] [Full Text] [Related]

  • 25. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells.
    Kim MH, Cho HS, Jung M, Hong MH, Lee SK, Shin BA, Ahn BW, Jung YD.
    Int J Oncol; 2005 Jun 15; 26(6):1669-74. PubMed ID: 15870884
    [Abstract] [Full Text] [Related]

  • 26. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
    Velusamy T, Shetty P, Bhandary YP, Liu MC, Shetty S.
    Biochemistry; 2008 Jun 17; 47(24):6508-17. PubMed ID: 18494499
    [Abstract] [Full Text] [Related]

  • 27. Helicobacter pylori stimulates urokinase plasminogen activator receptor expression and cell invasiveness through reactive oxygen species and NF-kappaB signaling in human gastric carcinoma cells.
    Kim MH, Yoo HS, Kim MY, Jang HJ, Baek MK, Kim HR, Kim KK, Shin BA, Ahn BW, Jung YD.
    Int J Mol Med; 2007 Apr 17; 19(4):689-97. PubMed ID: 17334646
    [Abstract] [Full Text] [Related]

  • 28. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
    Chang HJ, Kim MH, Baek MK, Park JS, Chung IJ, Shin BA, Ahn BW, Jung YD.
    Anticancer Res; 2007 Apr 17; 27(5A):3411-7. PubMed ID: 17970088
    [Abstract] [Full Text] [Related]

  • 29. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 30. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
    Hagiwara H, Sato H, Shirai S, Kobayashi S, Fukumoto K, Ishida T, Seki T, Ariga T, Yano T.
    Life Sci; 2006 Apr 04; 78(19):2249-54. PubMed ID: 16289236
    [Abstract] [Full Text] [Related]

  • 31. Tissue urokinase-type plasminogen activator receptor levels in breast cancer.
    Gong SJ, Rha SY, Chung HC, Yoo NC, Roh JK, Yang WI, Lee KS, Min JS, Kim BS, Chung HC.
    Int J Mol Med; 2000 Sep 04; 6(3):301-5. PubMed ID: 10934293
    [Abstract] [Full Text] [Related]

  • 32. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 33. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U, Prenzel KL, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM.
    Pancreas; 2008 Mar 01; 36(2):173-7. PubMed ID: 18376309
    [Abstract] [Full Text] [Related]

  • 34. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A, Scarlett CJ, Jackson CJ, Allen BJ, Smith RC.
    Pancreas; 2008 Mar 01; 36(2):160-7. PubMed ID: 18376307
    [Abstract] [Full Text] [Related]

  • 35. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2005 Sep 01; 14(3):777-82. PubMed ID: 16077991
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor.
    Nozaki S, Endo Y, Nakahara H, Yoshizawa K, Hashiba Y, Kawashiri S, Tanaka A, Nakagawa K, Matsuoka Y, Kogo M, Yamamoto E.
    Oral Oncol; 2005 Nov 01; 41(10):971-7. PubMed ID: 16129656
    [Abstract] [Full Text] [Related]

  • 37. Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion.
    Shyu KG, Hsu FL, Wang MJ, Wang BW, Lin S.
    Exp Cell Res; 2007 Apr 01; 313(6):1181-91. PubMed ID: 17335808
    [Abstract] [Full Text] [Related]

  • 38. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q, Liang LJ, Peng BG, Zhen YY.
    Ai Zheng; 2006 Nov 01; 25(11):1433-8. PubMed ID: 17094916
    [Abstract] [Full Text] [Related]

  • 39. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM, Johns A, Morser J, Dole WP, Greaves DR, Deng GG.
    J Cell Physiol; 2005 Jul 01; 204(1):73-82. PubMed ID: 15573379
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.